Page 1

Gregory B Stock, Ph.D. CURRICULUM VITAE greg@gregorystock.net APPOINTMENTS/EMPLOYMENT 2019 – present Adjunct Professor, Institute of Next Generation Healthcare, Icahn School of Medicine, NY 2017 – present Founding CEO, Stock Productions 2012 – present Board of Directors, Nutralogix 2010 – present Board of Directors, Dermalogix 2003 – present Founding CEO, Signum Biosciences (to 2010), Signum Board of Directors (to present) 2015 – 2019 Research Professor, Dept of Genetics and Multiscale Biology, Icahn School of Medicine 2015 – 2019 Co-Director, Harris Center for Precision Wellness, Icahn School of Medicine at Mt. Sinai 2017 – 2018 Board of Directors, SONGH Foundation 2014 – 2015 Consultant, Icahn Institute, Icahn School of Medicine at Mt. Sinai 2010 – 2014 Founding CEO (to 2012), CTO (to 2014), Director (to 2014), Ecoeos 2007 – 2010 Associate Director, Center for Life Sciences Policy, UC Berkeley 2005 – 2008 Associate Director, BioAgenda Institute 1998 – 2008 Founding Director: Medicine, Technology and Society Program, UCLA School of Medicine 2006 – 2008 Visiting Scientist, UCLA School of Medicine, Department of Pediatrics 2002 – 2005 Visiting Professor, UCLA School of Public Health, Department of Health Services 2001 – 2002 Visiting Scholar, Princeton University, Department of Molecular Biology 1998 - 2001 Visiting Professor, UCLA School of Medicine, Dept. of Psychiatry and Biobehavioral Sciences 1997 – 1998 Director, Science, Technology, and Society Program; Center for the Study of Evolution and the Origin of Life, UCLA 1994 – 1997 Visiting Senior Fellow, Center for the Study of Evolution and the Origin of Life, UCLA 1993 – 1994 Visiting Fellow, Princeton University - Woodrow Wilson School, Center of Domestic and Comparative Policy Studies 1993 – 1994 Adjunct Professor, Tulane University, Department of Molecular and Cell Biology 1989 – 1992 Visiting Scholar, UCLA School of Medicine, Department of Anatomy and Cell Biology 1987 – 1989 President, Magazine Discoveries. President, Stock & Breznau Publishing 1980 – 1985 Senior Member of Technical Staff, Transaction Technologies, Citicorp EDUCATION 1985 – 1987 Harvard Business School

M.B.A.

1978 – 1980 University of California at Irvine

NRSA Postdoctoral Fellow (Mentor: Susan Bryant)

1977 – 1978 Johns Hopkins University

NRSA Postdoctoral Fellow (Mentor: Francis Carlson)

1972 – 1977 Johns Hopkins University

Biophysics, Ph.D.

1970 – 1970 Marine Biological Labs, Woods Hole Summer Physiology Program (Mentors: Sydney Brenner, Andrew Szent-Gyorgyi) 1966 – 1971 Johns Hopkins University

Biophysics, M.S Biophysics, B.A. (Minor in Physics)

1


HONORS/AWARDS 2000 – 2018 30+ one-on-one invited public debates on healthcare, biotech, and other science policy issues with: Francis Fukuyama (7), Jeremy Rifkin (4), Daniel Callahan (3), Leon Kass (2), George Annas (2), William Hurlbut (2), Michael Sandel (2), Nigel Cameron (2), Bill McKibben, Rudi Jaenisch, Glen McGee, Jeffrey Smith, Robert Thurman, Ray Kurzweil 2013 Invited to deliver the commencement address at Cranbrook Academy of Art 2005 Selected to serve on the Advisory Committee on Stem Cells and Reproductive Cloning for the California State Department of Public Health 2004 Finalist, World Technology Council Award for Bioethics 2004 Personal Profile – Lancet 2004 Schneiderman Distinguished Lectureship Recipient - UC Irvine 2004 LBJ Memorial Lectureship Recipient – University of Texas 2003 Wired Magazine Rave Award for Science 2003 EPA Panel Invited address – Genomics and Nanotech, Washington DC 2003 Distinguished Fellow Designation, UCLA Center for Society, the Individual, and Genetics 2003 Personal Profile – MIT Tech Review 2003 Kistler Prize: Best 2002 Science Book, Redesigning Humans: Our Inevitable Genetic Future 2002 Book Reviews of Redesigning Humans in both Science and Nature 2002 Wired Magazine Rave Nominee for best science book of 2002 2002 Personal Profile – Wall Street Journal (front-page) 2001 Joe Thorne Gilbert Lectureship Recipient, University of Texas, Austin 2000 Invited to submit advisory memo to President Clinton on Tech Challenges of the Next Century 2000 Bruce Stewart Memorial Lectureship Recipient, American Society Of Reproductive Medicine Select Honors Personal Profile – The New York Times Pre-2000: #1 NYT Best Seller for 8 weeks, Top 10 for 24 weeks, The Book of Questions Top-10 NYT Best Seller for 8 weeks, The Kids’ Book of Questions Jasse Award for Distinction in Leadership – Harvard Business School Entrepreneur-of-the-Year Award – Harvard Business School Baker Scholar – Harvard Business School Phi Beta Kappa – Johns Hopkins University

2


PATENTS 1. Stock et al, Genes and Genetic Variations Associated with Gene-Environment Interactions and Susceptibility to Mercury Toxicity. Provisional Application. Jul 2013. US Patent 61/859,171. This patent deals with a multigene risk matrix we developed at Ecoeos to determine the risk of neurobehavioral impairment from chronic childhood exposure to low levels of mercury. I conceptualized the effort and led the team engaged in the analytic work leading to the claims in the invention, made inventive and conceptual contributions to various claims in the patent filing, wrote portions of the filing. 2. Stock et al, Topical Compositions and Methods for Epithelial-Related conditions. May 2013. Divisional Application. US Patent13/722,430. This patent describes a class of chemical compounds and topical preparations developed at Signum Biosciences for reducing skin inflammation so as to alleviate various skin conditions. I was actively involved in the research activity leading to the various claims in the invention and made inventive and conceptual contributions to assorted claims in the patent filing. 3. Stock et al, Topical Compositions and Methods for Epithelial-Related conditions. Awarded Dec 2012. US Patent 8,338,648. This patent describes novel topical polyisoprenyl protein inhibitors with anti-inflammatory properties. I was actively involved in the research activity leading to the various claims in the invention and made inventive and conceptual contributions to assorted claims in the patent filing. 4. Stock et al, Compositions and Methods for Enhancing Cognitive Function. Awarded Jul 2012. US Patent 8,221,804. This patent deals with modulators of PP2A methylation with potential utility for enhancing health and well being and protecting against Alzheimer’s and Parkinson’s. I was actively involved in the research activity leading to the various claims in the invention and made inventive and conceptual contributions to assorted claims in the patent filing. 5. Stock et al, Methods of Identifying Modulators of PP2A Methylase. Awarded Sept 2010. US Patent 7,794,965. This patent deals with a set of novel screening assays for identifying potential therapeutics that modulate PP2A methylation and have beneficial health impacts, including therapeutic effects for Alzheimer’s. I was actively involved in the research activity leading to the various claims in the invention and made inventive and conceptual contributions to assorted claims in the patent filing. 6. Lee, Seung-Yub et al, Acid Mimic Compounds for the Inhibition of Isoprenyl-S-Cysteinyl Methyltransferase, Jul 2009, US Patent 12/326746. This patent identifies novel chemistries that impact G-Protein signaling and have potential therapeutic activity for a variety of inflammatory conditions. I was actively involved in the research activity leading to the various claims in the invention and made inventive and conceptual contributions to assorted claims in the patent filing. 7. Stock et al, Modulation of Protein Methylation and Phosphoprotein Phosphate. Feb 2007. PCT/US03/07658. I was actively involved in the research activity leading to the various claims in the invention and made inventive and conceptual contributions to assorted claims in the patent filing. 8. Stock et al, Compositions and Methods for Enhancing Cognitive Function. Divisionals. Aug 2006 and Aug 2007. US Patent 11/346706 and 11/890278. These divisional applications are related to methods of using PP2A methylation modulators isolated from natural products including coffee beans that can be used to enhance and protect cognitive function. I was actively involved in the research activity leading to the various claims in the invention and made inventive and conceptual contributions to assorted claims in the patent filing. 9. Stock et al, Compositions and Methods for Treating Inflammatory Conditions. June 2006, awarded 2009. PCT/US2006/023022. This patent deals with novel compositions for modulating signal transduction so as to treat inflammatory conditions. Actively involved in the research activity leading to the various claims in the invention and made inventive and conceptual contributions to assorted claims in the patent filing. 10. Summer, J., G. Stock. Method of Making a Tooth Spacer. Awarded Jan 2003, US Patent 6,509,540. This patent deals with a method for creating an ultrathin polymer spacer that can be used during dental restoration procedures. I co-developed the strategy for approaching this dental intervention and made inventive contributions to various claims in the patent.

3


11. Summer, J., G. Stock. Method and Apparatus for Shaping Dental Filling Material. This patent involves a novel holder for use with polymer sheets that can be used for shaping dental composite materials. Awarded Nov 2002. US Patent 6,482,005. I worked on the strategy for approaching this dental intervention and made inventive contributions to various claims in the patent. 12. Summer, J., G. Stock. Tooth Spacer, Awarded Jul 2002, US Patent 6,425,760. This patent involves an ultrathing polymer tooth spacing device. I co-developed the strategy for developing this dental intervention and made inventive contributions to assorted claims in the patent. OTHER PROFESSIONAL ROLES 2010 – present Advisory Board, Center for Policy on Emerging Technologies (CPET), Washington DC. 2010 – present Advisory Board, Brain Preservation Foundation. 2006 – present Medicine and Biotech Advisory Board, Lifeboat Foundation 2006 – present Advisory Council, Extropy Institute 2005 – present California Advisory Committee on Stem Cells and Reproductive Cloning, Department of Health Services, State of California 2005 – present Editorial Board, Journal of Rejuvenation Research 2002 – present Editorial Board, Journal of Evolution and Technology 2007 – 2009 Editorial Board, International Journal of Bioethics 2005 – 2008 Advisory Board, BioAgenda Institute 2004 – 2007 Associate, Center for Society and Genetics, UCLA 2000 – 2007 Editorial Board, American Journal of Bioethics, MIT 2003 – 2006 Advisory Board, Extropy Society 2004 – 2006 Cognitive Phenomics Exec Committee, UCLA Neuropsychiatric Institute, UCLA School of Medicine 2001 – 2003 Scientific Advisory Board, Lifetree Technologies 2001 – 2003 Executive Committee of IAIMS (Integrated Advanced Information Management Systems) Project: Infoshare. UCLA School of Medicine 2000 – 2003 Scientific Advisory Board, Nexgenics 2002 Executive Committee, UCLA, Center on Society, the Individual, and Genetics 2000 – 2001 Senior Science Advisor & Host: Doctors, Designers, Visionaries, LE Vision Productions, Germany 1992 Candidate, U.S. House of Representatives, California 36th Congressional District RESEARCH PROFILE My research has ranged broadly. In the Biophysics Department at Johns Hopkins, I pioneered a novel photoncorrelation-spectroscopy assay of bacterial motility and worked through some analytic obstacles to the interpretation of complex laser light scattering in biological systems. This helped establish a foundation for the application of advanced computational techniques to the use of lasers in biology. As computational power expanded and laser technology improved, many applications in research and diagnostic settings emerged. Such technology, previously associated primarily with physics, grew into a robust research tool in the life sciences. During my tenure as CEO of Signum Biosciences, I helped establish a research effort to develop novel screening assays to identify naturally occurring molecules impacting the reversible methylation of PP2A, a key protein phosphatase and master regulatory switch. I was a co-inventor on several of the patents produced by this effort, which helped clarify the role of tau in neurodegenerative diseases such as Alzheimer’s and other Tauopathies.

4


As the CSO of Ecoeos, I orchestrated and helped execute a comprehensive and penetrating analysis of data from a 500-subject, 7-year NIH longitudinal study to identify the neurobehavioral impacts of chronic, low-level, mercury exposure. This pioneering work in personalized ecogenetics produced a clinically useful, multi-gene index of individualized vulnerability to neurotoxicity from childhood exposure to mercury. At the Harris Center, I helped bring together a robust clinical research program to develop innovative approaches to enhancing wellness through highly personalized interventions in the domains of sleep, diet, and activity. Research at the Harris Center was focused on small, carefully chosen clinical populations, validation of select devices and technologies, identification of early biomarkers of incipient disease, and the development of novel digital tools to assist in long-term behavior modification. IMPACT My most enduring impacts have come through my teaching activities, which have included public presentations, invited keynotes, policy debates, media appearances, guest lectures, books, public writings, and influential symposia I’ve convened and/or organized to grapple with difficult policy issues. This activity, which reached large academic and non-academic audiences at a critical time for biology and for society as a whole, has generated substantive impacts on the tone and content of the international debate about the policies and possibilities of modern genomics, advanced biotech, and emerging life-science technology. Engineering the Human Germline, a high-profile symposium I orchestrated at UCLA featuring James Watson, Lee Hood and Daniel Koshland, for example, garnered page-one coverage in the New York Times and in conjunction with the books I wrote in this arena, led me into wide-ranging public lectures, to appointment to the California Stem Cell Advisory Committee, where I continue to serve, and to one-on-one policy debates with Francis Fukuyama, Leon Kass, Ray Kurzweil, Jeremy Rifkin and other leading figures. Presentation forums ranged from NPR’s Talk of the Nation and Science Friday, to Charlie Rose, the BBC, TED, TEDMED, PopTech, and other cutting-edge venues. As the Human Genome Project began to reach its objectives, I was among the group of national and international voices shaping public and policy discussions about the possibilities and dangers of genomic technology, and worked to fend off calls for restrictive research regulations that threatened to stifle key areas of biomedical research. The disruptive possibilities emerging in Healthcare and Wellness today are far more immediate and concrete than those of a decade ago and represent the leading edge of a profound shift for healthcare, for society, and for our understanding of what it means to be human. My long and active involvement with emerging technology in the life sciences, its intersections with technology innovation in general, and the public discourse surrounding new technology positions me to play a strong role with other thoughtful, articulate voices at Mt Sinai to help calibrate and shape public expectations, to refine Mt. Sinai’s institutional strategy, and to ease our path to nextgeneration medicine and healthcare. GRANTS AND FOUNDATION SUPPORT Investment funds rather than grants and foundation support have been the most significant funding route for my activities. This included approximately $10 M in Equity funding to support Signum Biosciences. While CEO of Signum, we also won grants from the Alzheimer’s Drug Discovery Foundation for ~$500k, from the Michael J Fox Foundation for ~$300k, from the New Jersey Economic Development Authority for $1M (structured as a long-term research loan), from the New Jersey Commission on Science and Technology for $500k, from the NIH Small Business Innovation Research Program for ~$2.5M in phase 1 and phase 2 funds, and from the US Department of Health and Human Services’ Therapeutic Discovery Program for ~$600k. At Mt Sinai, I was actively involved with the acquisition of the $5M foundational gift made by the Harris Family Charitable Foundation to establish and support the Harris Center.

5


CLINICAL TRIALS PARTICIPATION I have been involved in the conceptualization and oversight of Clinical Trials in non-academic settings. As a member of the Board of Directors of Napo Pharmaceuticals, I was active in monitoring the complex phase 2/3 adaptive FDA trial of Crofelemer -- a fast-tracked candidate therapeutic for secretory diarrhea associated with HIV antiretroviral treatment. My involvement extended from 2007 to 2009, when this pharmaceutical property was licensed to Salix Pharmaceuticals. The multicenter Crofelemer trial cost some $20 M and involved approximately 400 patients. It was successful, and the antidiarrheal drug, the FDA’s first oral botanical drug, was approved in 2012. Crofelemer was initially marketed in human populations under the name Fulyzaq™, and is now marketed by Jaguar Pharmaceuticals under the name Mytesi™. At Signum biosciences, I was involved with the strategy and design of various small cosmetic and pilot trials for acne and skin inflammation. At Mt. Sinai, I was active in the design of a small trial (60 subjects) to evaluate the reliability of the new, highly promoted Theranos LDT laboratory testing process based on finger-prick blood collection. This study was the first to demonstrate the problems associated with that technology. Mt Sinai IRB approval for this trial was granted in June 2015. Clinical execution by the Hope Research Institute in Phoenix, Arizona was completed in 2015, and the results were published in 2016. TEACHING ACTIVITIES I have engaged in teaching activities both inside and outside of academic settings. Below is a selection of invited presentations at colleges and universities; educational symposia I’ve organized, convened or lectured at in educational venues such as libraries, town halls, and conference centers; and general media presentations that have been educational in focus. I view this latter category as very significant given that these presentations of mine have reached far more people and policy makers, and have exerted far greater influence on critical debates about science and healthcare policy than have my activities within more traditional academic settings. NOTE: Where presentations have been preserved and made available on a continuing basis through electronic media, I’ve also included them in the Media Resource Section. Teaching Activity

Level

Role

Audience Size, Venue (audience size is a loose estimate of the in-person audience unless otherwise noted)

# Of Hrs/Mos/Yrs

Evaluation Summary

Years

(where not a one-time lecture)

Nextgen Healthcare: A Global Disruption of Medicine and Healthcare Approaches

Physicians and Medical Staff

Guest Lecture

~250 at Baylor School of Medicine, Bioethics and Policy Forum

Invited lecture

N/A

2017

The Dawn of Nextgen Healthcare: What It Means to Be Human

Online access for general public

Lecture, debate, with video

100 at Vatican conference – Cellular Horizons: The Impacts of Technology

Invited lecture and debate

N/A

2016

The Coming Disruption of Healthcare: Business Challenges and Opportunities

Members of World Entrepreneurship Council

Lecture, with video

500 at the World Entrepreneurship Council Annual Meeting, New Delhi, India

Invited Lecture

N/A

2016

Biotech & the Future of Human Evolution

General Public

Guest Lecture

250 attendees at World Affairs Council

Invited lecture

N/A

2015

A Look into our Biological Future

General Public

Guest Lecture

~500 attendees at Victoria University

Invited lecture

N/A

2015

6


Innovation & Science as Instruments of Development

Broadcast to general public in Brazil (with translation)

video

~1,000 attendees at Valor Econômico Biotechnology, in Sao Paulo

Invited lecture

N/A

2014

The Truth about GMO’s

Broadcast to general public

video

100 attendees at Vail Symposium, broadcast on C-Span

Invited debate

N/A

2014

Ecogenetics: Implications For Medicine & Society

Broadcast to Executive Education Session

Video

~200 attendees Singularity University, Stanford

Invited Lecture

N/A

2013

Cracking Your Genetic Code

Broadcast to General Public

Video

Broad National Distribution. NOVA Productions (WGBH), Boston.

Invited Interview

N/A

2012

Biomarkers For Mercury Toxicity

Genomics Environments & Traits Conference Presentation

Guest Lecture, Online Video

~300 attendees at GET Conference. Harvard Medical School

Invited Lecture

N/A

2012

Genomic Science

Undergraduate Honors Course

Guest Lecture

~200 Students UCLA. Simulcast to Tokyo University.

Guest Lecture for 4 years.

NA

2007 – 2010

Challenges Of Living Longer

Broadcast to General Public

Podcast

National Distribution. Sage Podcast

Invited Interview

N/A

2009

Skin Science

Graduate Level Course

Guest Lecture

~40 Students Princeton University

Guest Lecture

NA

2009

Future Life

Broadcast to General Public

Video

Broad National Distribution. Discovery Science Channel, NY

Invited Commentary

N/A

2008

Should Human Germline Engineering be Banned?

BioAgenda East Debate, Biotech Policy

Keynote with Nigel Cameron

~250 Biotech execs, academics, students. Distributed as Video

Invited Appearance

N/A

2008

The Ethics & Realities Of Genetic Enhancement

Broadcast to General Public

Video

PBS: Religion & Ethics KUHT Productions Broad National Distribution.

Invited Program Segment

N/A

2007

Genomics, Science Fiction & Ethics Collide

Invited Presentation to Undergraduates

Guest Lecture Video

~400 attendees Wheaton College

Guest lecture

N/A

2007

Genomics & The Human Future

Invited Presentation to Students and Faculty

Guest Lecture

UCLA

Guest lecture

N/A

2006

The Effects Of Media On Medical R&D

Invited Presentation to Undergraduates

Guest Lecture

~400 attendees Presbyterian College

Guest lecture And Panel Discussion

N/A

2006

Genomic: Medical Possibilities, Ethical Constraints

Invited Presentation to Undergraduates

Guest Lecture

~300 attendees Auburn University

Guest lecture

N/A

2006

Biotech Hopes & Fears

Invited Presentation to Undergraduates

Guest Lecture

~400 attendees University of Spokane

Guest lecture

N/A

2006

7


Genetic Engineering In Medicine, Agriculture, & Law

Invited Presentation to Students

Guest Lecture

~250 attendees UCLA School of Medicine

Guest lecture

N/A

2005

Genetics & The Future Of Medicine

Broadcast to General Public

Panel Discussion& Debate

NPR: To The Point with Warren Olney. Broad National Distribution.

Program Segment

N/A

2005

Genetics, Biomedicine, & Healthcare

LBJ Distinguished Lecture. Open to General Public

Guest Lecture

~ 500 attendees University of Texas

Named Lectureship

N/A

2004

Questions & Risk Taking

Invited Presentation to Undergraduates

Guest Lecture

~400 attendees University of Richmond

Guest lecture

N/A

2004

Biotech & Bioethics

Invited Presentation to Undergraduates

Guest Lecture

~300 attendees University of Delaware

Guest lecture

N/A

2004

Genetics & Society: The Challenges Ahead

Invited Lecture to Graduate and Medical students

Guest Lecture

~200 attendees Harvard Medical School

Guest lecture

N/A

2004

The Economic Impacts Of Biotechnology

Invited Lecture to Students and Alumni

Guest Lecture

~400 attendees Harvard Business School

Guest lecture

N/A

2004

Science, Ethics, & The Stem Cell Research Human Future Distinguished Panel. Open to general Public

Guest Lecture

~600 attendees Princeton University

Panel Discussion

N/A

2004

Human Error & Technology

Broadcast to General Public

Guest Segment

NPR: To The Point with Warren Olney. Broad National Distribution.

Program Interview

N/A

2004

Human Enhancement

Broadcast to General Public

Debate/ Discussion

NPR Point/Counterpoint Broad National Distribution.

Debate

N/A

2004

Redesigning Humans: Best Hope Or Worst Fear

Broadcast to General Public

Appearance and Online Video

TED audience of 2,000 450,000 online views Monterey.

Invited talk

N/A

2003

Genomics & Our Health

Broadcast to General Public

One of two Participants.

KPCC/NPR with Larry Mantle. Broad Distribution.

Discussant

N/A

2003

The Search Of Immortality – Dialogue with Jay Olshanky,

Broadcast to General Public

One of two Participants.

KPCC/NPR with Larry Mantle. Broad Distribution.

Discussant

N/A

2003

Brave New World: The Challenges To Come

Invited Presentation to Undergraduates and Graduates

Guest Lecture

~500 attendees University of Texas

Guest lecture

N/A

2003

Genetics & Reproductive Biology: A Look Ahead Steamboat

Invited Lecture to Physicians for Continuing Education

Guest Lecture

~150 attendees Intl. Soc. for Advancement of Humanistic Studies in Medicine Colorado

Guest lecture

N/A

2003

Cloning & Public Policy

Undergraduate Course Lecutre

Guest Debate

~100 attendees Princeton University

Guest lecture

N/A

2002

8


Genomics & The Future Of Medicine

Presidential Lecture to Undergraduates and Graduates

Guest Lecture

~400 attendees Rice University

Guest lecture

N/A

2002

A Look At The Human Future

Invited Presentation to students

Guest Lecture

~750 attendees Univ. of Washington, Evans School of Public Affairs

Guest lecture

N/A

2002

Bioethics & Public Policy

Broadcast to General Public

Dialogue with NPR: Talk of the Nation. Leon Kass Broad National Distribution.

1 hour Appearance

N/A

2002

Enhancing The Human: Genomics, Science Fiction, & Ethics Collide

Invited Presentation to Undergraduates

Guest Lecture

~400 attendees Tennessee State University

Guest lecture

N/A

2002

Genetics & Culture

Invited Presentation to Undergraduates, Graduates, and Faculty

Guest Lecture Webcast

~250 attendees SINAPSE UCLA Dept. of Design & Media Arts

Guest lecture

N/A

2002

Debate With Francis Fukuyama.

Broadcast to General Public

One of two debaters

PBS: Charlie Rose, Point/Counterpoint with Francis Fukuyama. NY. Broad National Distribution.

Guest Interview

N/A

2002

Are We Playing God?

Broadcast to General Public

3-person panel

PBS: World at Large, David Gergen. NY Broad National Distribution.

Guest Appearance

N/A

2002

Regulatory Questions: Stem Cells, Clones, & Designer Children.

Broadcast to General Public

Interview

France 2. Broad National Distribution.

Guest Appearance

N/A

2002

Talking About Designer Children

Broadcast to General Public

Internet Live Chat.

BBC Science Broad National Distribution.

Guest Segment

N/A

2002

The Embryo Protection Law

Broadcast to General Public

Television Segment

ARTE: German Public TV. Broad National Distribution.

Appearance

N/A

2002

Frontiers Of Aging: The Ethics Of Extending The Human Lifespan

Undergraduate Honors Course

Guest Lecture

~100 attendees UCLA

Guest lecture

N/A

2001

Joe Thorne Gilbert Lectureship

Joe Thorne Gilbert Lectureship to Student Class

Guest Lecture

~1000 attendees University of Texas

Guest lecture

N/A

2001

Braving The New World: Benefits & Challenges Of Genetic Knowledge

Invited Presentation to Undergraduates

Guest Lecture

~300 attendees Univ. of Michigan, Ann Arbor

Guest lecture

N/A

2001

Homo Ex Machina: Tied To Our Flesh.

Invited Keynote to general public

Guest Lecture

~1000 attendees North Rhine-Westphalia Science Center, Dusseldorf

Guest lecture

N/A

2001

9


The Human Genome Project: Implications For The Human Future

Invited Presentation to Undergraduates and general public

Guest Lecture

~500 attendees Texas A&M International

Guest lecture

N/A

2001

Genomics & Biotech

Invited Presentation to Undergraduates

Guest Lecture

~400 attendees Florida State College

Guest lecture

N/A

2001

Genetic Privacy & Insurance.

Broadcast to General Public

Guest appearance

NPR: To The Point with Warren Olney. Broad National Distribution.

Segment appearance

N/A

2001

From IVF To Germline Modification: Coming Challenges & Possibilities In Reproductive Medicine

Invited Presentation to IVF physicians, CME Credits

Guest Lecture

~200 attendees Fertility Society. Boston.

Guest lecture

N/A

2001

Human Genetic Engineering,

Broadcast to General Public

Guest Appearance

ARTE: German Public TV. Broad National Distribution.

Show Segment

N/A

2000

Eugenics & The Nazi Lebensborn Program,

Broadcast to General Public

Guest Interview

The History Channel Broad National Distribution.

Edited Interview

N/A

2000

How Does Technology Transform Society?,

Broadcast to General Public

One of 5 panelists

PBS: Closer to Truth, Broad National Distribution. Season 2, Ep 10

Partic. on 60 minute panel

N/A

2000

Will Gene Therapy Change The Human Race?

Broadcast to General Public

One of 5 panelists

PBS: Closer to Truth, Broad National Distribution. Season 2, Ep 5

Partic. on 60 minute panel

N/A

2000

Can We Imagine The Far Future – Year 3000?

Broadcast to General Public

One of 5 panelists

PBS: Closer to Truth, Broad National Distribution. Season 2, Ep 1

Partic. on 60 minute panel

N/A

2000

Does Sex Have A Future?

Broadcast to General Public

One of 5 panelists

PBS: Closer to Truth, Broad National Distribution. Season 1, Ep 14

Partic. on 60 minute panel

N/A

2000

Can You Really Extend Your Life?

Broadcast to General Public

One of 5 panelists

PBS: Closer to Truth, Broad National Distribution. Season 1, Ep. 8

Partic. on 60 minute panel

N/A

2000

The Human Experience: At The Crossroads Of Medicine, Science, & Technology

Invited Presentation to Undergraduate and Alumni

Guest Lecture

~200 attendees UCLA

Guest lecture

N/A

2000

Global Consciousness: An Evolutionary Perspective On High Technology

Invited Presentation to Undergraduates

Guest Lecture

~300 attendees Pepperdine University

Guest lecture

N/A

1999

Hard Cases In Genethics

Invited Presentation to Undergraduates

Guest Lecture

~300, University of Memphis

Guest lecture

N/A

1999

10


Biology, Technology, & Human Future Evolution

Invited Presentation to Undergraduates and general public

Guest Lecture

~500 attendees UC Irvine

Guest lectureship

N/A

1999

Cloning In Biomedicine: Applications & Controversies. Human Germline Engineering

Invited Keynote to OBGYN and IVF Physicians

Guest Lecture

~400 attendees Argentina’s Center of Studies in Gynecology & Reproduction Magisterial Tribune

Guest lecture

N/A

1999

Taking Stock Of Our Future. Boston

Invited Presentation to Alumni

Guest Lecture

~300 attendees Harvard Business School

Guest lecture

N/A

1997

Public Policy Options For Biotechnology

Invited Presentation to Undergraduates, fellows, and faculty

Guest Lecture

~50 Students Woodrow Wilson School, Princeton University

Guest lecture

N/A

1994

Strategies For Engineered Negligible Senescence

Mind, Technology & Society Program Open to General Public

Lecture Video & Proc.

~600 attendees Mind, Technology & Society Talk Series UCLA.

Guest lecture

N/A

ADMINISTRATIVE LEADERSHIP APPOINTMENTS INTERNAL: Co-Founder, Co-Director, Harris Center for Precision Wellness, Icahn Institute for Genomics and Multiscale Biology, Mt. Sinai School of Medicine. I worked with co-director Joel Dudley and the development office to help secure the Center’s initial funding of $5M from Joshua Harris, and I have had a significant role in defining and articulating the strategy and vision for the Center, and in orchestrating its activities. Our goal for the next few years is to establish the Center as a leading player in the move towards next generation healthcare. Towards this end, we are yoking the emerging hi-tech sensors of physiological tracking with the omic and analytic technologies at the heart of the Icahn Institute. Establishing a solid foundation for new approaches to health assessments and interventions that enhance wellbeing by bringing early disease detection and personalizing approaches to wellness will require substantial clinical work, robust collaboration, significant fundraising, clear vision, solid science, and effective execution. I will be actively involved in bringing this about. EXTERNAL: Founder, Director, Program on Medicine, Technology and Society, UCLA School of Medicine – I founded this program at UCLA’s School of Medicine with the support of UCLA Chancellor, Albert Carnesale, UCLA Medical School Dean of Research, Leonard Rome, and the Physician-in-Chief of the Mattel Children’s Hospital, Edward McCabe. The Goal of the Program was to explore the possibilities and challenges associated with emerging advances in biotechnology, AI, machine learning, and genetics. The program orchestrated a half-dozen highprofile symposia, created an educational website, and captured sufficient institutional support at UCLA to create the Center for Genomics and Society. Annual Symposia, lectures and courses continue to this day within that descendant of the MTS program.

11


Co-founder, CEO, Board Member, Signum Biosciences – This biotech, a spinoff of Princeton University, had the goal of extending and commercializing potent signal-transduction technologies involving G-Protein signaling and the modulation of Protein Phosphatase 2A. The company raised and spent some $20 M during my tenure there and achieved our original goals through multiple publications, NIH grants, patents, collaborative ventures, products, and research partnerships with institutions like GlaxoSmithKline, Elisabeth Arden, Princeton University, University of Pennsylvania, Cornell Weil, and Rohto Pharmaceuticals. Signum has spawned two successful subsidiaries – Signum Nutralogix and Signum Dermalogix – and in 2016 anticipates drawing royalties from products with more than $500 M in retail sales. Co-Founder, CEO, CSO, Board Member, Ecoeos – This company was established to commercialize personalized genetic tests for individualized risk from exposure to mercury and other environmental toxins. The company raised $2.5M, developed a consumer test for Hg exposure risk, and did an alpha launch. It ran into financing difficulties following the FDA’s crackdown on 23andMe for unregulated consumer testing, and Ecoeos is now pursuing a clinical path in collaboration with the Cleveland Clinic. PUBLICATIONS Peer Reviewed Original Contributions 1. Kidd, Brian A., et al. "Evaluation of direct-to-consumer low-volume lab tests in healthy adults." The Journal of clinical investigation 126.5 (2016): 1734-1744. 2. Pillai, P, Woods, J, Gauderman, J, Hytopoulis, E., Frazier, T., Stock, G. 2013 Genetic Potentiation of Risk for Neurobehavioral Deficits from Childhood Exposure to Mercury: Analysis of Longitudinal Data from the Casa Pia Dental Amalgam Study, Ecoeos Online Publication 3. Stock, G, Callahan, D. 2008. The Effects of Life Extension. Rejuvenation Research, Vol 10, #3 407-417 4. Stock, G 2007. Germinal Choice Technology and the Human Future. Reproduction and Biomedicine. Mar 10 Supplement 1:27-35 5. Stock G. 2004. The Pitfalls of Planning for Demographic Change, Ann NY Acad Sci, 2004 Jun; 1019:546-51* 6. Stock G., Callahan, D. 2004 Would Doubling the Human Life Span Be a Net Positive or Negative for Us Either as Individuals or as a Society, J Gerontol A Biol Sci Med Sci 59(6): B554-B559 doi:10.1093/gerona/59.6.B554 7. De Grey, J. Baynes, D. Berd, C. Heward, G Pawelec, G. Stock. 2002. “Is human aging still mysterious enough to be left only to scientists?” Bioessays, 24(7), 667-676 2002 8. De Grey, A. B. Ames, J. Anderson, A Bartke, J. Campesi, C. Heward, R. McCarter, G. Stock. 2002 “Time to Talk SENS: Critiquing the Immutability of Human Aging,” In: Harman, D., Ed., Increasing Healthy Life Span: Conventional Measures and Slowing the Innate Aging Process; Proc. 9th Congress of the International Association of Biomedical Gerontology. Annals of the New York Academy of Sciences, 959:452-462 9. Stock, G. 2000. Genetic Profiling, Cloning, and Germline Enhancement: Challenges to Come. In Jahrbuch für Recht und Ethik, Annual Review of Law and Ethics Vol 8: C. Byrd, J. Hruschka, J. Joerden, eds., Duncker & Humblot, Berlin 10. Stock, G. 1999. Human Germline Engineering: Implications and Prospects. In Jahrbuch für Recht und Ethik, Annual Review of Law and Ethics Vol 7. C. Byrd, J. Hruschka, J. Joerden, eds., Duncker & Humblot, Berlin 11. Conway, K., S. Lozenoff, G. Stock, R. Hunt. 1984. Numerical Resectioning Used to Quantitate the 3D Structure of Chimeric Xenopus Eyes. Anatomical Record 208:35A 12. Stock, G., S. Bryant. 1981. Studies of Digit regeneration and their Implications for Theories of Development and Evolution of Vertebrate Limbs. Journal of Exp. Zoology 216:423-433. 13. Stock, G., G. Krasner, N. Holder, S. Bryant. 1980. Frequency of Supernumerary Limbs Following Blastemal Rotation in the Newt. Journal of Exp. Zoology 214:123-126 14. Stock, G. 1978. Measurement of Bacterial Translation by Photon Correlation Spectroscopy. Biophys. J. 22:79-96

12


15. Goll, J., G. Stock. 1977 Determination by Photon Correlation Spectroscopy of Particle Size Distributions in Lipid Vesicle Suspensions. Biophys. J. 19:265-273 16. Stock, G. 1977. Photon correlation Spectroscopy - An Assay of Bacterial Motility. Ph.D. Thesis. Biophysics Department, Johns Hopkins University 17. Stock, G. 1976. Application of Splines to the Calculation of Bacterial Speed Distributions. Biophys. J. 16:535-540 Other Peer Reviewed Publications 1. Stock G. 2003 “From Regenerative Medicine to Human Design: What are we really afraid of?” DNA and Cell Biology 11:679-684 2. Stock, G. 2003. “If the goal is relief, what’s wrong with a placebo?” American Journal of Bioethics, 3(4): 534, 2003. 3. Stock, G. 2001. “Eggs for Sale – How much is too much?” American Journal of Bioethics, 1(4):26-27 4. Stock, G. 2001. “The Family Covenant: A Flawed Response to the Dilemmas of Genetic Testing.” American Journal of Bioethics, 1(3):17-18. 5. Stock, G. 2001. “Choice or Chance: Why not pick our children’s gender?” American Journal of Bioethics, 1(1):36-37. 6. Stock, G. 2000 Der Geist Ist Aus Der Flasche (The Genie is out of the Bottle), Der Spiegel, pp. 190-192, Apr 10. Invited Contributions 1. Stock, G. 2011, B-Digital Commentary: Frontiers of the Medical Technology (ICT) evolution, Congress of Information and Communications 2. Stock, G 2006. Das Orakel – Gregory Stock uber kinder nach mass. Die Zeit. Euro NR 5, pp72-74 3. Expert Declaration, 2000, Analysis of Medical Board v. Chen, Superior Court of California. 4. Stock, G. 2000 L'égalité des chances pour tous. Invited Commentary, Remaking our bodies: What we can expect from genetic engineering. Liberation, Paris. Sept 16, 2000. Books 1. The Kids’ Book of Questions. Revised and Reissued. 2014. Stock, Gregory. Workman, NY. 2. The Book of Questions. Revised and Reissued. 2013. Stock, Gregory, Workman, NY 5 printings, 125,000 in Print 3. Redesigning Humans: Our Inevitable Genetic Future. 2002. Stock, Gregory. Houghton Mifflin (US), Profile (Britain), Japan, Italy. (Paperback Title: Redesigning Humans: Choosing our Genes, Changing our Future), 2003, Mariner Press. 4. Engineering the Human Germline: An Exploration of the Science and Ethics of Altering the Genes We Pass to Our Children, 2000. Editors: Gregory Stock and John Campbell. Oxford University Press. 5. Metaman: The Merging of Humans and Machines into a Global Superorganism. 1993. Stock, Gregory. Simon & Schuster (NY), Doubleday (Toronto), Bantam (Britain), Mondadori (Italy) Kadakawa (Tokyo), Soho (China) 6. Business, Politics, and Ethics: The Book of Questions. 1991. Stock, Gregory. Workman, NY. 100,000 in print 7. Love and Sex: The Book of Questions.1989. Stock, Gregory. Workman, NY. 23 printings. 650,000 in print. Translations: Hungarian, Italian, Japanese, Spanish, Portuguese, Korean 8. The Kids' Book of Questions. 1988. Stock, Gregory. Workman. NY. 25 printings. 700,000 in print. Translations: German, Hungarian, and Japanese

13


9. The Book of Questions. 1987. Stock, Gregory. Workman, NY. 78 printings. 2.7 million in print. Translations: Spanish, French, Italian, Chinese, German, Swedish, Dutch, Danish, Norwegian, Finnish, Japanese, Portuguese, Icelandic, Hebrew, Hungarian, Slovakian, and Bulgarian. 10. The Book of Questions. 1985. Stock, Gregory. Stock & Breznau Publishing Co., Los Angeles. 3 printings. Book Chapters 1. Stock, G. 2013, The Battle for the Future, pp. 302-316 in The Transhumanist Reader: Classical and Contemporary Essays on the Science, Technology and Philosophy of the Human Future, Editors Natasha Vita-More, Max More. Wiley-Blackwell Press. 2. Stock, G. 2013. Nothing is going to be the same, pp169-182 in Secrets of Inferno: In the footsteps of Dante and Dan Brown, Arne de Keijzer, Editor, Story Plant Press 3. Stock, G. 2003. “Biotechnology and the Future of Medicine” in Biotechnology and the Future of Society, UAE Press, 2003 4. Stock, G. and J. Campbell. 2002. Public Policy Recommendations for Human Germline Engineering: In Current Controversies: Genetic Engineering, The Gale Group 5. Stock, G. 2001. “The Coming Era of Human Biological Re-design” In The Future is Ours – Evolution and Enlightenment, ed. George Enninga, Gordon and Breach Arts International, London & OPA Publishing. Amsterdam 6. Stock, G. 2000. “The Century Ahead” in Visions of the Future from Leading Thinkers, White House Publication; Invited Contribution, Internal Distribution 7. Campbell, J., G. Stock. 2000. A Vision for Practical Human Germline Engineering. Chapter 2, pp. 9-17 in Engineering the Human Germline, eds. G. Stock and J. Campbell. Oxford Univ. Press, NY 8. Stock, G., J. Campbell. 2000. Germline Intervention: An Evolutionary Perspective. pp. 2-8 in Engineering the Human Germline, eds. G. Stock and J. Campbell. Oxford Univ. Press, NY 9. Stock, G., J. Campbell, L. Hood, J. Watson et al. 2000. The Road Ahead: A Panel Discussion. pp.73-98 In Engineering the Human Germline, eds. G. Stock and J. Campbell. Oxford Univ. Press, NY 10. Stock, G., J. H. Campbell. 1996. Human Society as an Emerging Global Superorganism: A Biological Perspective. Pp181-199 In Evolution, Order, and Complexity, editor Kenneth Boulding, E. Khalil. Routledge Press, NY 11. Goll, J., G. Stock. 1983. Determination of Particle Size and Speed Distributions using Photon Correlation Spectroscopy and First-Order Splines. Chapter 6 of Measurement of Suspended Particles by Quasi-Elastic Light Scattering. Editor Barton Dahneke, Wiley and Sons, NY 12. Stock, G., F. Carlson. 1975. Photon Correlation Spectra of Wobbling and Translating Bacteria in Symposium on Swimming and Flying in Nature 1: 57-68. Editors T.Y. Wu, C. Brokaw, C. Brenan. Plenum. NY. Non-Peer Reviewed Publications 1. Stock, G. 2014. Assessing Standards of Evidence in Ecogenetic Testing for Sensitivity to Mercury and Other Environmental Toxins. Ecoeos White Paper 103. Ecoeos Online Publication. 2. Stock, G. 2013. Mercury Sensitivity in Adults and Children. Ecoeos White Paper 102, Ecoeos Online Publication. 3. Stock, G 2005. The Coming Possibilities of Reproductive Biology and Genetics, Global Agenda Report 2005, The Economist 4. Stock, G 2005, From Regenerative Medicine to Human Design: What Are We Really Afraid Of? Spoletosciencia Magazine. Sept 5. Stock, G 2005, The Coming Possibilities of Human Redesign. La Recherche, Paris 6. Stock, G. 2004. From Regenerative Medicine to Human Design: What are we really afraid of? Free Inquiry Magazine. Jun 24(4):27-30 7. Stock, G, Zavos, P. 2004. Point Counterpoint: Titans of Cloning. Popular Science, Feb

14


8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30.

31. 32.

Stock, G. 2004. Seizing Control of the Human Future, Free Inquiry Magazine, Jan Stock G. 2003. Stamp out Short People, Opinion Piece, Wired Magazine, p126, Oct Stock, G. 2003. Designer Babies and Social Inequality, RSA Journal. Stock, G. 2003. Entering the Genomic Era with Our Eyes Wide Open, UCLA Today, Jan 22. Stock, G. 2003. Genetic Research: Ban or Not Ban, Current Affairs 448:3-7, Dec. Stock, G and F. Fukuyama 2002. Biotechnology: Our Slippery Slope? (An exchange of letters), Prospect 75: 16-20, Jun Stock, G. 2002. “Choosing our Children’s Genes.” The Futurist. Jul/Aug Stock, G. and F. Fukuyama 2002. Point – Counterpoint: “Should we allow genetic technologies with the potential to alter human biology,” Reason, Jun Stock, G 2002 “Do We Pull Back in Fear or Embrace the Future?” London Times Higher Education Supplement. May 17 Stock, G. 2002 “Homo ex Machina,” in Jahrbuch 2001/2002 des Wissenschaftszentrums NordrheinWestfalen, ed. Gert Kaiser, Wissenschaftszentrum Nordrhein-Westfalen, Duesseldorf, Germany. Stock, G. Excerpt, Redesigning Humans. 2002 The Sunday Times, London, May Stock, G. 2002. “The Future of Human Reproduction.” BBC Science Now. Jan Stock, G. 2001. “Unvermeidbare Designer-Babys” Invited Guest Commentary, Deutschland Financial Times, p. 30, Dec 6 Stock, G. 2001. “The Genie is Out of the Bottle,” Opinion Piece, Deutschland Magazine, Apr, 2001 Stock, G 2000. Commentary in chapters 7, 8, 9 -to-Truth Series, editor Robert Kuhn, McGraw-Hill, 2000 Stock, G. 2000. “Reflections on the Future of IVF and Germline Engineering.” ASRM News, Vol. 34, No. 4, Winter 2000 Stock, G. 2000 “Genetik: Die Vision vom Klon-Baby,” Visions of Clones in Was Ist Liebe? Focus Magazine 52:122-125 (Dec 22), Germany Stock, G. 2000 Playing God. BMW Magazine, Apr Stock G. 2000. Patent Pending: The Debate About Gene Patents, UCLA Magazine, Spring, Vol12, #1. Stock, G. 2000. End of the Beginning: The Genomics Revolution, UCLA Today, page 7, Aug 29 Stock, G. 1998. Point de Vue: Faut-il modifier la lignee germinale? Biofutur 178:5. Paris. Stock, G. 1998.The Prospects for Human Germline Engineering, Teleopolis, Frankfurt, Germany Stock, G. 1998. Human Germline Engineering: The Prospects for Commercial Development. Contribution to Published Workshop on Genetic Manipulation in Animals. Advanced Technology Program, National Institute of Standards and Technology, Wash DC Stock, G., G. McGee. 1997. Should Human Cloning be Banned? Brain-Tennis Written Point-Counterpoint Debate, HotWired Stock, G. 1996. The Fourth Phase: Our Evolutionary Transition to a New Epoch in the History of Life, in Evolution, editor E. Todd Ellison, Meridian Press, Los Angeles

15


INVITED LECTURES/PRESENTATIONS NOTE: Where presentations have been preserved and made available on a continuing basis through electronic media, I’ve also included them in the Media Resource Section. TITLE / TOPIC

VENUE

Date

Oncology, AI, and The Human Future: Chaos and Order Collide

Miami Breast Cancer Conference

2019

The Future of Personalized Healthcare From Healthcare to Health: An Impending Disruption

Colorado Association of Hospitals, Vail

2018

Harvard Business School Alumni Association

2018

Driving Innovation in Healthcare

Cipla Pharmaceutical Leadership Meeting

2018

Nextgen Healthcare: A Global Disruption of Medicine and Healthcare Approaches

Baylor School of Medicine, Bioethics and Policy Forum Lecture, Houston

2017

Technological Breakthroughs in the Life Sciences: The Economic Consequences for Asia

Asian Leadership Conference. Seoul, Korea

2016

The Dawn of Nextgen Healthcare: What It Means to Be Human

Cellular Horizons: How Science, Technology, Information and Communications Will Impact Society. The Vatican

2016

Nextgen Healthcare: Implications for the Developing World.

Resilience and Innovation Summit, Havana, Cuba

2016

The Coming Disruption of Healthcare: Business Challenges and Opportunities

World Entrepreneurship Council Annual Meeting, New Delhi, India

2016

Keynote: Technology and Chronic Disease

Chronic Disease Foundation, Dallas

2015

Keynote: Nextgen Healthcare -National Pharmacy Congress, Istanbul Medicine as an Information Science.

2015

Biotech & the Future of Human Evolution

World Affairs Council, Philadelphia

2015

A Look into our Biological Future

Victoria University, Canada

2015

Keynote: The Coming Transformation of Healthcare & Medicine

Turkey Innovation Summit, Izmir

2014

Keynote: Innovation & Science as Instruments of Development

Valor Econômico Biotechnology, Sao Paulo

2014

The Truth about GMO’s: A Debate With Jeffry Smith

Vail Idea Symposium, Vail (filmed by C-Span)

2014

The Prospects for Telemedicine

KNX Radio, Los Angeles

2014

Ecogenetics: Implications for Medicine & Society

Singularity University, Stanford

2013

Opportunities in a Time of Disruption

Cranbrook Academy Commencement Address

2013

16


Keynote: Being Human in a Digital Age

Applied Brilliance: Questions & Values in our Hi-Tech World, NY

2013

Essential Questions in an Era of Technology & Transformation.

Seattle Town Hall. Seattle

2013

The Courage to Question.

Powell’s Book Store, Portland

2013

Genetic Engineering & the Future of Medicine: A debate with Nigel Cameron.

Brown University Debate Series, Providence

2013

Procrastination & Uncertainty

A Conversation with John Perry, San Francisco

2013

The Book of Questions: Ethics & Values.

Nationally Syndicated Radio Appearances: The Financial Safari, The Allan Handelman Show, Viewpoints, The Bill Martinez show

2013

Envirogenomics & the Future of Healthcare

Cleveland Clinic, Personalized Healthcare Summit Cleveland 2013

Keynote: Biotech & Human Sustainability,

Fashion Group International: Inspiration & Imagination. NY


2013

From Darwin to Destiny: Redefining Humans

Advancing Humanity Symposium: Trajectories & Timelines for Radical Biotech, Stanford University, Stanford

2013

Cracking Your Genetic Code

NOVA, Public Broadcasting System, WGBH, Educational Foundation, Boston

2012

Un Monde Sans Humains,

Borrel, P. et al, ARTE France & Cine-TV

2012

Keynote: 
Smart World: The Next Frontiers of Biotech & Healthcare

B Digital Global Conference, Barcelona

2011

Envirogenomics: Ecoeos & The Genetics of Susceptibility to Mercury

JP Morgan Healthcare Conference, San Francisco

2011

Genetic Susceptibility & Environmental Toxins

Social Venture Network Fall Conference, Philadelphia

2011

Genetic Engineering: The Hope & Hubris of Playing God

ThinkFest, Goa, India

2011

Genetics, Transhumanism & the Human Future

Singularity University, Stanford

2011

Studio 360:
The Human Design Show

NPR, KNYC, NY

2011

Systems Biology, Big Data, & the Future of Experimentation

Maddock Douglas Futurist Lab for Blue Cross Blue Shield, Chicago

2011

The Digital & Biotech Revolutions

Decisions Makers 2010: Shaping Future Societies, Frankfurt, 2010 Germany, May 1999

Being Human in a Transformative Technological Age: An Exchange between Gregory Stock & Robert Thurman

Teknion New Idea Salon, NY

2010

Future Babies

Veja Media, Brazil

2010

17


Natural Products, Global Regulation, & the Future of Pharmaceuticals

NPR Biotech Nation, San Francisco

2010

Keynote: Medicine of the Future: The Next Century.

Abbot India Centennial Convocation Mumbai, New Delhi

2010

Senior Living, Biotech, & the Human New Aging Symposium. U Penn School of Architecture, Future. Philadelphia,

2010

Keynote: Global Competition in Biotech & Pharma: A look Ahead

Seoul Forum. Seoul, Korea

2010

Keynote: The Coming Transformation of Healthcare

Turkish Pharmacy Annual Congress. Ankara, Turkey

2010

Keynote: Life After Darwin

Vibes in Biosciences Symposium Leuven, Belgium

2010

Evolution & the Posthuman Future

Singularity Summit, San Francisco,

2010

New Approaches to Alzheimer’s

Neurotech Summit. Boston

2010

Biotechnology & Genomics

Key Emerging Policy Issues, UCLA, Los Angeles

2010

Pharmaceuticals & Cosmetics: the landscape Today

Skin Deep Symposium. Rutgers

2009

Religion & Ethics: Genetics & the Human.

Biola University, Los Angeles.

2009

Human 2.0

France 2 Interview, Paris

2009

Challenges of Living Longer

Sage Podcast Feature

2009

Humans & Machines

O Estado de S. Paulo, Brazil

2009

The Surrogates

Cameo solo film appearance and interview

2009

Therapies for Alzheimer’s & Parkinson’s

Neurotech Presentation, Boston

2009

Biotech & the Human Future, an interview with Michio Kaku

Visions of a Universal Humanity, Humanity Ascending Documentary, Talk Radio Network program

2009

Keynote with Nigel Cameron: Should Human Germline Engineering be Banned?

BioAgenda East Great Debate, Biotech Policy

2008

Debate on Healthcare Policy with Daniel Callahan

Edmonton Aging Symposium.

2008

Exploring the Future

Henry Less Productions. Toronto 2008

2008

Future Life

Discovery Science Channel, NY

2008

Gattaca Commentary

Special Edition DVD, commentary and appearance

2008

Point Counterpoint on Human Enhancement: A conversation with Michael Sandel

NPR: Connections

2008

The Health Revolution

Scribemedia

2008

The Ethics & Realities of Genetic Enhancement

PBS Religion & Ethics Newsweekly, KUHT Productions

2007

18


Opening Keynote: Genomics & our Rights

Civil Liberties Research Centre, Alberta, Canada

2007

Opening Keynote: New Approaches World Future Society, Minneapolis to Healthcare

2007

Fallen Angels

Umbrella Films Production, Los Angeles

2007

Our Biotech Future

CBS Radio

2007

The Shape of the Human Future

VNU Media, NY

2007

Opening Keynote: Trends in Health, Science & Nutrition.

American Dietetic Association, Honolulu

2006

Keynote: The Era of Personalized Medicine

Medco, Orlando

2006

Regenerative Medicine: A Look Ahead

Forrest Technology Group, Pittsburg

2006

Panel: Chimeras & Synthetic Life

BioAgenda Institute, Palm Springs

2006

The Evolution of the Biotech Revolution

Applied Biosystems, Chicago

2006

From AI to Global Brain, the Merging of Human & Machine

Ernst & Young, Las Vegas, Nevada,

2005

The Challenges of the Next Millennium

Foundation for the Future, Seattle, WA

2005

Keynote: From Pharmacogenomics to Genetic Design: A look ahead

World Transhumanist Society, Annual Conference, Caracas, Venezuela

2005

Spoletoscienza: Biotechnology & the Human Future

Festival dei due Mondi, sponsored by Sigma Tau, Spoleto, Italy

2005

A New Path Towards Therapeutic & Pharmaceutical Development

Price Waterhouse Cooper Showcase: Signum Biosciences. NY

2005

Keynote: Biotech & the Human Future, Steamboat

FTI Annual Convention, Colorado, (other keynote given by George Bush. Sr.)

2005

Genetics & the Future of Medicine

NPR: To The Point with Warren Olney

2005

The Politics of Stem Cell Research

Princeton Democratic Club

2005

Signum Biosciences Research Overview

Princeton Entrepreneurs Network, Boston

2005

Coming Biotech Challenges.

BioAgenda, Palm Springs

2004

Germline Research Policy Options

Center for Public Policy Washington DC,

2004

Keynote: The Future of the Pharmaceutical Environment

Economist Pharma Conference, Athens, Greece.

2004

A Look at Our Reproductive Future

Royal Society of London. London

2004

Afflicted by the FDA: A Look Towards the Future of Pharmaceutical Regulation & Healthcare

TEDMED, Charleston, SC

2004

19


Evolution, Enhancement & the Automobile

Nissan Motor Company, Los Angeles

2004

Keynote: Risk Assessment & Genomics.

GlaxoSmithKline. Wilmington, VA

2004

From Regenerative Medicine to Genetic Design

UC Irvine, Schneiderman Distinguished Lecture, Irvine

2004

Biotechnology & the Human Future

High Tech Showcase, Princeton

2004

Human Error & Technology

NPR: To The Point with Warren Olney

2004

Keynote Debate with Daniel Callahan: Should we try to Control Human Aging?

Kronos Longevity Health Science Symposium. Phoenix

2003

Panel Moderator: The Challenge of Nanotechnology.

Environmental Protection Agency SAB Meeting. Washington, 2003 DC

Panel Moderator: Genomics & Risk Assessment.

Environmental Protection Agency SAB Meeting. Washington, 2003 DC

Our Genetic Future

National Philanthropy Roundtable Debate with William Hurlbut, San Diego

2003

Redesigning Humans

PopTech, Portland, Maine

2003

Biotech, Medicine, & the Challenges Ethics Society, Los Angeles Ahead,

2003

Biotechnology & the Human Future

Summit on Biotechnology, Denver

2003

Preparing society for a possible second epidemiological transition.

International Association of Biomedical Gerontology, Queens' College, Cambridge

2003

Opening Keynote: 21st Century Opportunities & Challenges

World Future Society, San Francisco

2003

Keynote debate with George Annas: Transhumanism & Bioethics in the 21st Century. Yale. Should Humanity Resist Genetic Paths Towards the Posthuman?

2003

Genomics & Healthcare

Johnson & Johnson Strategy Meeting, Orlando

2003

The Future of Genetics: Debate between Gregory Stock & Francis Fukuyama. Moderated by Matt Ridley

Center for Life. Commemoration of the 50th Anniversary of the determination of the structure of DNA. Newcastle, UK

2003

“Research on Aging in America�

Christ Hospital Health Alliance, Cincinnati

2003

Should we unravel the biology of aging? A Debate between Gregory Stock & Bill McKibben. Moderated by Morton Kondracke.

Alliance on Aging Crossroads Debate, Washington, DC

2003

Challenges Of The Biotech Revolution,

San Diego Science & Technology Council. San Diego

2003

Keynote: Future Challenges in Biotechnology.

Reason Foundation. San Diego

2003

Genetics & Reproductive Biology: A look Ahead Steamboat

ISFAHSIM (Intl. Soc. for Advancement of Humanistic Studies 2003 in Medicine). Colorado

20


Redesigning Humans: Best Hope or TED 2003 (Technology, Education, & Design Conference). Worst Fear. Monterey

2003

Biotechnology & the Future of Medicine.

Center for Strategic Studies & Research. Abu Dhabi, UAE

2003

Genomics, Science Fiction & Ethics Collide

Wheaton College, Boston

2003

The New Nuclear Family

FM4 Vienna

2003

Genomics & our Health:

KPCC. Discussion with Ed McCabe & Larry Mantle

2003

Point of View Interview

MIT Tech Review

2003

The search for Immortality

NPR, Discussion with Jay Olshanky, Pasadena

2003

The Storefront Genome, the Individual & Genetics

UCLA Center for Society. Convener & Moderator

2003

Growth Hormones & Human Enhancement

Wired Radio

2003

Our Biotech Future.

ABC National Radio

2002

Keynote: Biotechnology, Bioinnovation, Bio-ethics.

University of Louisville. Louisville.

2002

Uncommon Wisdom: The Challenges of Biotechnology: A debate with Leon Kass.

PBS. San Francisco

2002

Keynote: Innovation in a shifting world, Istanbul,

National Quality Congress,

2002

Keynote: Biotechnology & Bioethics.

Venturewire. Lifescience Portfolio Conference San Francisco.

2002

Biofutures, Biostrategies.

Association for Strategic Planning. Los Angeles.

2002

Keynote: Biotechnology, Medicine, & the Human Future.

Cato Institute. Carmel.

2002

Keynote: Our biotech Future

GlaxoSmithKline. Toronto

2002

Ethics: Can we make germline modification an acceptable procedure? Panel with Michael Blaese, Jacques Cohen, Mark Frankel, Eric Parens.

American Society of Gene Therapy. Boston

2002

Opening Keynote: The Coming Healthcare Revolution

HIMS (Healthcare Information Management Society). Las Vegas.

2002

A Posthuman Future? Public Debate between Gregory Stock & Frank Fukuyama,

Institute of Ideas, Logan Hall, Institute of Education, London, 2002

Keynote: Science, Medicine, & Technology.

Carnegie Museum of Science. Pittsburg.

2002

Genomics meets Reproductive Biology: Challenges to the Human Future.

Microsoft Corporation. Bellevue.

2002

21


Redesigning Humans: Our Inevitable Genetic Future.

UC Santa Barbara Arts & Letters Santa Barbara

2002

Biotech Future vs. Human Future: Keynote Debate with Ray Kurzweil.

Foresight Institute Palo Alto

2002

Public Policy Implications of the Genomics Revolution

New America Foundation, Santa Cruz

2002

Keynote: Future Visions.

Hewlett Packard. Zurich

2002

Keynote: Visions of the Coming Millennium,

Foundation for the Future. Seattle

2002

The Genetic Future Is Now Cato Institute. Washington, DC. Redesigning Humans vs. Regulating Science. Debate with Francis Fukuyama.

2002

What is the case for allowing genetic and other biological manipulations with the potential to change human beings? “A PointCounterpoint with Francis Fukuyama.

Reason Online

2002.

The Implications of the Human Genome Project for Business & Insurance.

Lloyds (IT Direct), London

2002

Future Human Evolution

Coast-to-Coast AM with Art Bell

2002

Charlie Rose Interview

PBS, NY

2002

The Human Genome Project

Dallas Woman's Club

2002

Redesigning Humans

Coast-to-Coast AM with Art Bell

2002

The Truth about Cloning

Channel 4, Richard & Judy Show, London

The Embryo Protection Law

ARTE Television

2002

Brave New Man

ARTE Television, Host, Filmed in China, Iceland, US

2002

Today Programme

BBC Radio 4, London

2002

Talking about Designer Children

BBC Science, Internet Live Chat

2002

BBC News Hour

BBC World Service, London

2002

BBC Science in Action

BBC World Service, London

2002

Our Biotech Future

Bloomberg, Canadian Broadcasting Corp, People Magazine, 2002 Newsweek, Wall Street Journal, LA Times

Discussion of Redesigning Humans with Bryan Gumble

CBS -- The Early Show

2002

To The Best of Our Knowledge: Human Evolution

Minnesota Public Radio

2002

Regulating Cloning. A Critique of Brownback.

MSNBC

2002

22


Debate with Leon Kass: Bioethics & Policy

NPR – Talk of the Nation

2002

Redesigning Humans

NPR (KPCC), Larry Mantle Show, Los Angeles

2002

Redesigning Humans. San Francisco,

NPR (KQED) – Tech Nation with Moira Gunn

2002

Regulatory questions: stem cells, clones, & designer children

France 2

2002

What Unifies Art & Science?

PBS – Closer to Truth

2002

“Are We Playing God?” A discussion with Michael West & Thomas Murray.

PBS – David Gergen, World at Large, NY

2002

The Challenges of Biotechnology: A debate with Leon Kass

PBS – Uncommon Wisdom, San Francisco

2002

A Look at the Human Future

Tech TV

2002

Germinal Choice Technology: Our Evolutionary Future

The Futurist Online, Online commentary & interview.

2002

Cloning & Beyond.

USA Radio Network with Dan Miles

2002

Braving the New World: Benefits & Challenges of Genetic Knowledge.

University of Michigan. Ann Arbor

2001

Homo ex Machina: Tied to our Flesh.

North Rhine-Westphalia Science Center. Dusseldorf

2001

Opening Keynote: Debate with Jeremy Rifkin: Regulating Biotechnology?

Regulatory Affairs Professional Association, Baltimore

2001

Plenary Address: Genomics meets Reproductive Biology – A look at the Human Future.

International Symposium on Genomics & Biotechnology. Chinese Academy of Sciences. Hangzhou, China.

2001

From IVF to Germline Modification: Coming Challenges & Possibilities in Reproductive Medicine.

Boston Fertility Society. Boston

2001

Genomics meets Design: A Look at the Human Future.

UCLA Department of Design & Architecture. Streaming Culture Series

2001

Keynote: Genomics & its Impacts on Society & Medicine

The Design Group. Applied Brilliance Summit, Sedona, Arizona

2001

Keynote: Biotech Futures.

Mackenzie Financial Conference. San Francisco,

2001

The Human Genome Project – Ethical Impacts & the Future of Medicine.

University of Texas, Gilbert Endowed Lecture. Austin,

2001

The Regulation of Biotech

ABC: Justice Talking Live. Washington, DC

2001

Keynote: The Human Genome Project Meets the Internet – The Coming Revolution in Healthcare & Medicine

The Road To Discovery. Solucient National Conference, Orlando

2001

23


Strategies for Regulating Germline Engineering.

UCSD, Bioethics Debate La Jolla, California.

2001

Keynote: The Genomics Revolution & The Future of Medicine.

Columbus Medical Association. Ohio

2001

Assessments of Cloning

ABC Radio. Charlie Warner Show

2001

Un Monde Sans Humains,

ARTE France & Cinétévé, Philippe Borrel, Paris

2001

Future Talk: Engineering the Human Business Radio Network Germline.

2001

The Science of Cloning

CNN International. Q&A

2001

The Question of Cloning

CNN International. Q&A

2001

The Perils & Promise of Genomics

Commonwealth Club, San Francisco

2001

Biotech & the Trajectory of Life

Fashion Group International, NY

2001

The Weldon Bill, Cloning, & Research: Point – Counterpoint

FOX

2001

Coming Ethical Challenges

Frontiers of Knowledge, UCLA Foundation Retreat, San Diego

2001

Brave New World: Investing in the Genetic Era

Investment Funds Institute of Canada, Toronto

2001

The Human Race: Into The Body,

MediaOne

2001

The Human Genome Project: The Next Frontier

Newport Beach Public Library Association

2001

Genetic Privacy & Insurance.

NPR – To The Point, Warren Olney

2001

How distant is Human Cloning?

NPR – To The Point, Warren Olney

2001

Beyond Human: The Body Electric

PBS – Thomas Lucas Productions,

2001

Opening Keynote Debate with Jeremy Rifkin: Regulating Biotechnology?

Regulatory Affairs Professional Association, Baltimore

2001

Strategies for Engineering Negligible Medicine, Technology & Society Program. UCLA. Los Senescence II: In praise of prizes Angeles

2001

Commentary on Therapeutic Cloning.

NPR: To The Point with Warren Olney

2001

Selecting the Future: Should we be able to choose the Sex of Our Children?

UCLA Alumni Relations, Host & Moderator, Westwood

2001

Live from the Peace Room: Visions of a Universal Humanity

Wisdom Radio

2001

The Ethical, Social, & Political implications of retarding or even reversing aging, ,

SENS Conference. Oakland Children’s Hospital, Oakland

2000

Ethics & Hope: The Future of Medicine in The Genomic Era,

Millennium Days Impulse Speaker. Kassel, Germany.

2000

24


Keynote: In vitro fertilization & Germline modification – A Look Ahead.

Bruce Stewart Memorial Lecture. ASRM (The American Society of Reproductive Medicine) San Diego

2000

Science, Medicine, & Ethics in Diagnosing & Treating Embryos.

Goethe Institute. San Diego,

2000

Our Biological Future: a look 10, 1000 & 1,000,000 years into the future.

University of Pennsylvania Center for Bioethics & Templeton Foundation. Philadelphia.

2000

The Challenge of Innovation in the Life Sciences,

Herbert Quant Foundation, Transatlantic Forum

2000

Athletes of the 21st Century

ESPN

2000

How Does Technology Transform Society? A Robert Kuhn roundtable – Gregory Stock, Francis Fukuyama, Marvin Minsky, George Kozmetsky, Greg Benford

PBS: Closer to the Truth (Season 2 Episode 10)

2000

Will Gene Therapy Change the Human Race? Robert Kuhn roundtable – Gregory Stock, Francisco Ayala, French Anderson, Sherwin Nuland, Allan Tobin

PBS: Closer to the Truth (Season 2 Episode 5)

2000

Can We Imagine The Far Future – Year 3000? A Robert Kuhn roundtable – Gregory Stock, Edward de Bono, Bart Kosko, Graham T. T. Molitor, Bruce Murray

PBS: Closer to the Truth (Season 2 Episode 1)

2000

Designer Children

ABC Television

2000

Cryogenic Preservation – Prelude to Alcor Foundation, Asilomar Non- destructive or Destructive information Retrieval

2000

Human Genetic Engineering

2000

ARTE – German Public TV

The New Man: Biotechnology driven Bavarian Broadcasting Corp, Munich Change in Humans & Society

2000

Closer to the Heart.

BBC TV Special on Retarded Aging

2000

Genetics & the Future.

BBC Live Web Chat event

2000

Newsweek: Designer Children

BBC Radio Scotland

2000

Cloning the First Human

BBC Horizon

2000

Debate with Jeremy Rifkin: Cloning.

CNN Talkback Live

2000

Babies by Design

CNN Talkback Live

2000

Beyond the Human Genome Project,

CNN Talkback Live

2000

It Runs In the Family – Sports ESPN Dynasties: Genetics or Environment.

2000

Facing The Next Millennium

2000

Foundation for the Future, Seattle

25


Gene Futures

FOX News

2000

Genetics & the Future,

German National Radio

2000

Keynote: Reflections on the Goethe Institute. Future Human Evolution: UCLA Los Challenges Ahead at Enhancing The Angeles Human: Genomics, Science Fiction & Ethics Collide.

2000

What We Can Expect From Genetic Engineering.

Liberation. Transcribed Interview. Paris

2000

Designer Babies

N3TV – Canadian Television

2000

Longevity & Aging

NPR-KQED Health Dialogues

2000

Does Sex Have a Future? A Robert Kuhn roundtable – Gregory Stock, Cliff Penner, Joyce Penner, Paul Abramson, Vern Bullough

PBS: Closer to the Truth (Season 1, Episode 14)

2000

Can You Really Extend Your life? A Robert Kuhn roundtable – Gregory Stock, French Anderson, Sherwin Nuland, Arthur S. De Vany, Roy Walford

PBS: Closer to the Truth (Season 1, Episode 8)

2000

The Atomic Man,

Science Fiction Channel

2000

Brave New World: Investing in the Genetic Age.

TD Asset Management. Toronto

2000

Eugenics & the Nazi Lebensborn Program

The History Channel

2000

Panelist: Computational Biology – Tracking the Genetic Blueprint

From Darwin to Destiny, UCLA. Los Angeles

2000

Select Pre 2000 Facing Biological Limits. San Francisco.

Foresight Institute: Nanotech & Biotech.

Biotech and the Human Future

Hoechst Triangle Forum Roundtable. Frankfurt, Germany,

New Genetics & Reproduction. Prospects for Human Design.

Gruter Institute for Law & Behavioral Research. Squaw Valley,

Cloning in Biomedicine: Applications & Controversies. Human Germline Engineering – A look ahead.

Argentina’s Center of Studies in Gynecology & Reproduction. Magisterial Tribune: Buenos Aires.

Millennial Specials.

BBC, Fox News.

Babies, Genetic Engineering & the Future,

BBC: Horizons

Exploring Creativity, Enterprise, & Progress, Humans: Objects of Conscious Design.

Dynamic Visions, San Jose, CA

26


Why Humans won’t Internalize Microchip-based Enhancement Technology in the Immediate Future.

Foresight “Group Genius” Weekend. Palo Alto

Foundation for the Future – Humanity 3000

Seattle

Looking at Gene Patenting

NPR-KCRW, Which Way LA

Will machines be conscious?

NPR-KCRW, Which Way LA

Will We Extend the Human Lifespan?

NPR-KPCC

Visions of the Future.

NPR-KPCC

How a Genetic Double-Screening Strategy can Elucidate Human Aging

The Kronos Group, Phoenix

Human Germline Engineering: Implications for Science & Society

A multimedia documentary funded by the Greenwall Foundation, UCLA Medical School

Visions of the Future

NPR-KPCC

The Prospects & Implications of Human Germline Work.

The Human Analyzed. Ethical & Legal Problems Confronting Human Genome Research. German Ministry for Education, Science, Research & Technology. Frankfurt

The Prospects for Human Germline Engineering,

Second Annual Conference on Mammalian Cloning: Implications for Sci. & Society. Washington, DC

Cloning & Germline Engineering

American Society of Artificial Internal Organs Annual Symposium. NY

Opening Remarks: An Evolutionary Perspective.

Engineering the Human Germline Symposium, UCLA

Technocalypse: Future Humans

Belgian National Television:

The Challenge of Cloning

Canadian Broadcasting Corp

Cloning & Beyond.

Danish National Television –

Satellites & Telecom.

NPR-KCRW, Which Way LA

The Future of Genetic Testing.

NPR-KCRW, Which Way LA

Human Germline Engineering – A New Look.

NPR-KCRW, Fresh Air

Revisiting Germline Engineering

NPR, The Morning Edition

The Truth about Science Fiction

The History Channel

Frankenstein’s Children.

German National Television

The Future of Humans.

Science Fiction Channel

Mysteries of the Millennium.

CBS Special

Visions of the Future World,

Department of the Army Biotech Conference. USAR Lab. Penn.

27


Global Warming, Species Extinction, & Population Growth

Institute for Bioenvironmental Research, Tulane. New Orleans.

Who's Driving Spaceship Earth?

Buckminster Fuller Centennial. San Diego,

The Coming Global Superorganism

World Future Society, Special Lecture. Boston

The Emergence of a Global Superorganism

Bionomics Institute. San Francisco

Costing the Earth: Threats to the Environment

BBC Radio, London

Science Now: The Future Evolution of Humans

BBC Radio, London

The Book of Questions

Larry King

Love & Sex, The Book of Questions

Oprah Winfrey

The Book of Questions

Oprah Winfrey

VOLUNTARY PRESENTATIONS NOT APPLICABLE (see abstracts) MEDIA RESOURCE EDUCATIONAL MATERIALS Some of my invited presentations have been filmed and used as media materials in educational contexts. Their intended audience has by and large been the informed general public and students, educators, and policy makers. A number of these like TED and TEDMED talks, various symposia, and productions with Charlie Rose, NOVA, and NPR are still readily available. Others are not. NOTE: Almost all of these have come from various presentations identified under invited lectures and teaching activities and listed there as well. 1. TED: Redesigning Humans: Best Hope or Worst Fear. Monterey, Feb 2003 – Online Video -- 450,000 views 2. PBS Charlie Rose – Point Counterpoint with Francis Fukuyama. NY, Jun 2002 3. PBS – Uncommon Wisdom: The Challenges of Biotechnology: A debate with Leon Kass. San Francisco, Oct 2002. 4. Gattaca Special Edition DVD -- Commentary on Human Genetic Manipulation. 2008 5. ARTE Television – Host: Brave New Man -- Filmed in China, Iceland, US Nov, 2002 6. NPR Talk of the Nation -- Debate with Leon Kass: Bioethics and Policy, Apr 2002 7. Fallen Angels, Umbrella Films Production, Video on Assisted Reproduction. Los Angeles 2007. 8. Engineering the Human Germline: Best Hope, Worst Fear. A UCLA Program on Medicine and Technology Website Exploration funded by the Greenwall Foundation, 2000 9. Singularity University - Ecogenetics: Implications for Medicine and Society. Stanford 2013 10. Cinétévé & ARTE -- 
Un Monde Sans Humains, Philippe Borrel, Paris 2012. 11. Wheaton College - Genomics, Science Fiction and Ethics Collide, Boston, 2007 12. NPR (KQED),Tech Nation with Moira Gunn -- Redesigning Humans. San Francisco, Apr 2002 13. KPCC (NPR) Larry Mantle – Genomics and our Health: Gregory Stock, Ed McCabe, Jan 2003 14. PBS Closer to the Truth: Can You Really Extend Your life? A Robert Kuhn roundtable – Gregory Stock, French Anderson, Sherwin Nuland, Arthur S. De Vany, Roy Walford, Season 1, Ep 8 2000 15. PBS Closer to the Truth: Will Gene Therapy Change the Human Race? Robert Kuhn roundtable – Gregory Stock, Francisco Ayala, French Anderson, Sherwin Nuland, Allan Tobin. Season 2, Ep 5 2000

28


16. PBS Closer to the Truth: How Does Technology Transform Society? A Robert Kuhn roundtable – Gregory Stock, Francis Fukuyama, Marvin Minsky, George Kozmetsky, Greg Benford, Season 2 Ep 10 2000 17. PBS Closer to the Truth: Does Sex Have a Future? A Robert Kuhn roundtable – Gregory Stock, Cliff Penner, Joyce Penner, Paul Abramson, Vern Bullough, Season 1, Episode 14 2000 18. PBS Closer to the Truth: Can We Imagine The Far Future – Year 3000? A Robert Kuhn roundtable – Gregory Stock, Edward de Bono, Bart Kosko, Graham T. T. Molitor, Bruce Murray. Season 2, Ep 1 2000 19. PBS Religion and Ethics KUHT Productions - The Ethics and Realities of Genetic Enhancement, Aug, 2007 20. KNX Radio -The Prospects for Telemedicine. Los Angeles. 2014 21. NOVA Productions (WGBH) -- Cracking Your Genetic Code, Boston 2012 22. NPR Biotech Nation, Natural Products, Global Regulators and the future of Pharmaceuticals, Moira Gunn and David Duncan, San Francisco, 2010 23. Visions of a Universal Humanity, Humanity Ascending Documentary, interview on Biotech and the Human Future, Talk Radio Network, program with Michio Kaku. 2009 24. FILM, The Surrogates -- Cameo appearance and interview. 2009 25. Sage Podcast -- Challenges of Living Longer, 2009 26. Estado de S. Paulo -- Humans and Machines, Brazil. 2009 27. Henry Less Productions Video -- Exploring the Future,. Toronto 2008 28. Discovery Science Channel -- Future Life, NY. 2008 29. Scribemedia.-- The Health Revolution, 2008. 30. CBS Radio -- Our Biotech Future, 2007 31. VNU Media, The Shape of the Human Future, NY, 2007 32. NPR, Genetics and the Future of Medicine, Warren Olney, To The Point, Aug 2005 33. NPR: To The Point with Warren Olney, “Human Error and Technology,” Jun 2004 34. NPR – Connections. Point Counterpoint on Human Enhancement with Michael Sandel. Apr 2004. 35. FM4 Vienna – The New Nuclear Family. Nov 2003 36. Wired Radio – Growth Hormones / Human Enhancement, Oct 2003 37. AM-Radio Redesigning Humans, Art Bell. Channel 4, Richard & Judy Show, The Truth about Cloning, London, May 2002 38. Tech TV -- A Look at the Human Future. Jun 2002 39. KABC (Kim Sarafin), WMAL (Charlie Warren), Radio Australia – The Human Fuutre. 40. Diverse Interviews on Human Cloning, CNN (Wolf Blitzer), FOX (Neal Cavuto), Canadian Broadcasting Corp, People Magazine, Newsweek, Wall Street Journal, LA Times. Dec. 2002 41. NPR (KPCC) – The search of Immortality – Discussion with Jay Olshanky, Pasadena, Aug. 2003 42. Minnesota Public Radio – To The Best of Our Knowledge: Human Evolution. Jun, 2002 43. PBS – David Gergen “Are We Playing God?” A discussion with Michael West and Thomas Murray. World at Large. NY, Jun, 2002 44. BBC World Service, News Hour, London, May 2002 45. BBC World Service, Science in Action, London, May 2002 46. BBC Radio 4. Today Programme, London, May 2002 47. Coast-to-Coast AM. Future Human Evolution -- Art Bell. May 2002 48. CBS -- The Early Show, Discussion of Redesigning Humans with Bryan Gumble. May, 2002 49. USA Radio Network with Dan Miles. Cloning and Beyond. May, 2002 50. The Futurist Online. Germinal Choice Technology: Our Evolutionary Future. Online commentary and interview. May 2002. 51. NPR (KPCC) -- Redesigning Humans: Larry Mantle Show. Los Angeles. May 2002

29


52. 53. 54. 55. 56. 57. 58. 59. 60. 61. 62. 63. 64. 65. 66. 67. 68. 69. 70. 71. 72. 73. 74. 75. 76. 77. 78. 79. 80. 81.

MSNBC – Regulating Cloning. A Critique of Brownback. Apr 2002 PBS – Closer to Truth: What Unifies Art and Science. Mar 2002 France 2 – Regulatory questions: stem cells, clones, and designer children. Jan 2002 BBC Science – Talking about Designer Children, Internet Live Chat. Jan 2002 ARTE Television -- The Embryo Protection Law, Jan 2002 To The Point – NPR (Warren Olney) Commentary on Therapeutic Cloning. Nov. 2001 Business Radio Network – Future Talk: Engineering the Human Germline. Nov. 2001 BBC Horizon. Cloning the First Human. Oct 2000 ABC Radio. Charlie Warner Show, Assessments of Cloning, Aug 2001. CNN International – Q&A, The Science of Cloning, Aug 2001 FOX – The Weldon Bill, Cloning, and Research: Point - Counterpoint. Jul 2001 NPR – To The Point, Warren Olney. Genetic Privacy and Insurance. Jun 2001 PBS – Beyond Human: The Body Electric. Thomas Lucas Productions, May 2001 CNN International, “Q & A -- The Question of Cloning.” Mar 2001 NPR – To The Point, Warren Olney. How distant is Human Cloning? Feb 2001 MediaOne – The Human Race: Into The Body, Jan 2001 Wisdom Radio – Live from the Peace Room: Visions of a Universal Humanity, Jan 2001 NPR-KQED Health Dialogues – Longevity and Aging, Dec 2000 BBC – Radio Scotland – Newsweek: Designer Children Oct 2000 German National Radio – Genetics and the Future, Sept 2000 FOX News – Gene Futures, Oct 2000 The History Channel – Eugenics and the Nazi Lebensborn Program, Jul 2000 ESPN – It Runs In the Family – Sports Dynasties: Genetics or Environment. Jul 2000 CNN – Talk Back Live: Beyond the Human Genome Project, Jun 2000 ABC Television – Designer Children, May 2000 Bavarian Broadcasting Corp -The New Man -Biotechnology driven Change in Humans and Society, Munich, Apr 2000. UCLA – From Darwin to Destiny: Panel: Computational Biology: Tracking the Genetic Blueprint, Los Angeles, Apr 2000 N3TV – Canadian Television – Designer Babies, Mar 2000 Science Fiction Channel – The Atomic Man, Mar 2000 BBC - Closer to the Heart. TV Special on Retarded Aging, Feb 2000

82. 83. 84. 85. 86. 87. 88. 89. 90. 91.

ARTE - German Public TV, Human Genetic Engineering, Feb 2000 CNN – Babies by Design. Jan 2000 ESPN - Athletes of the 21st Century Jan 2000 CNN - Talkback Live: Debate with Jeremy Rifkin – Cloning. Jan 2000 BBC - Genetics and the Future. Live Web Chat event. Jan 2000 NPR-KPCC Visions of the Future. Dec 1999 BBC, Fox News. Millennial Specials. Dec 1999 NPR-KCRW Which Way LA: Looking at Gene Patenting. Oct 1999 NPR-KCRW Which Way LA: Will machines be conscious? Sept 1999 UCLA Medical School. Human Germline Engineering: Implications for Science and Society. A multimedia documentary funded by the Greenwall Foundation. 1999 92. NPR-KPCC – Will We Extend the Human Lifespan? Apr 1999

30


93. BBC: Horizons: Babies, Genetic Engineering and the Future, Feb 1999 94. Belgian National Television: Technocalypse: Future Humans Nov 1998 95. The History Channel: The Truth about Science Fiction, Nov 1998 96. Danish National Television – Cloning and Beyond. Jun 1998 97. NPR-KCRW Which Way LA: Satellites & Telecom. Jun 1998 98. NPR-The Morning Edition: Revisiting Germline Engineering, Mar 1998 99. NPR-KPCC Fresh Air: Human Germline Engineering – A New Look. Mar 1998 100. Canadian Broadcasting Corp: The Challenge of Cloning Mar 1998 101. NPR-KCRW Which Way LA: The Future of Genetic Testing. Feb 1998 102. German National Television: Frankenstein’s Children. 1997 103. Science Fiction Channel. The Future of Humans. 1997 104. CBS Special: Mysteries of the Millennium. 1996 105. BBC Radio. Costing the Earth: Threats to the Environment. London, 1993 106. BBC Radio. Science Now: The Future Evolution of Humans. London, 1993 107. Oprah Winfrey – The Book of Questions (I hour), 1988 108. Oprah Winfrey – Love and Sex, The Book of Questions (I hour), 1989 109. Larry King – The Book of Questions (I hour), 1988 ABSTRACTS 1. Stock, G., K. Conway, R. Hunt. 1983, Computer-aided Reconstruction Used to Visualize the 3D Shape of Chimeric Xenopus Eyes. Society for Neuroscience Abstract 9:848 2. Stock G. 2003. “The Promises and Pitfalls of Planning for Demographic Change,” Biogerontology. p.89, vol 4, Supplement 1, 2003, Abstracts of the International Association of Biomedical Gerontology 10th Congress. Strategies for Engineered Negligible Senescence.

31

Profile for greg_stock

Gregory Stock, Ph.D. Curriculum Vitae  

Gregory Stock, Ph.D. Curriculum Vitae  

Advertisement